Skip to Main Content
LICENSES AND NOTICES

License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA websiteExternal Website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

These materials contain Current Dental Terminology, Fourth Edition (CDT), copyright © 2002, 2004 American Dental Association (ADA). All rights reserved. CDT is a trademark of the ADA.

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

  1. Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
  2. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association websiteExternal Website.
  3. Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
  4. ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
  5. CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.


Impact

Print | Bookmark | Email | Font Size: + |

News and Publications Medical Review News and Publications

Topic Publication Date Last Revised/Reviewed
Billing Not Otherwise Classified (NOC) HCPCS Code 03.18.2025  
Billing the Professional and Technical Components 02.27.2025  
Proper Billing of Tuberculosis Tests 07.16.2024  
Utilizing Modifier KX for Medicare Dental Claims 07.01.2024  
Documentation Guidelines for Evaluation & Management (E/M) Services: Reminders and Updates 04.09.2024  
Billing and Coding: JW and JZ Modifier Guidelines 06.27.2023  
When You Don't Respond to Additional Documentation Requests (ADRs): Quick Reference GuidePDF 06.16.2023  
Medicare Dental Service Coverage Update 06.08.2023  
J15 Targeted Probe Educate Review Status 05.25.2023  
Targeted Probe and Educate Program to Focus on Laboratory Testing 05.25.2023  
Targeted Probe and Educate Program to Focus on Annual Wellness Visits 05.25.2023  
SPRAVATO™ (esketamine) nasal spray, CIII 05.01.2023 12.21.2023
NCD 110.24: Chimeric Antigen Receptor (CAR) T-Cell Therapy Billing Instructions 03.10.2023  
Targeted Probe and Education Program to Focus on Spinal Pain Management Claims 01.04.2023  
MolDX: Pharmacogenomics Testing Policy Article Update 03.14.2022  
Billing and Coding Instructions: Cryoneurolysis 01.28.2022  
Triamcinolone Acetonide Injectable Suspension, for Suprachoroidal Use (Xipere™) Billing and Coding Instructions 01.25.2022  
Sinus Implant Billing and Coding Instructions 01.21.2022  
Radioactive Diagnostic Agents for Positron Emission Tomography (PET) of Prostate-Specific Membrane Antigen (PSMA) Positive Lesions in Men with Prostate Cancer Billing and Coding Instructions 01.20.2022  
Billing VEKLURY™ (Remdesivir) Antiviral Medication in Outpatient Settings 01.18.2022  
Qutenza (capsaicin 8% topical system) Billing and Coding Instructions 11.08.2021  
Piflufolastat F-18 ("Pylarify")(18F-DCFPyl or PyL) Billing and Coding Instructions 10.21.2021  
Targeted Probe and Educate (TPE) Process 09.02.2021  
CGS is Retiring Policy L34089 Human Papillomavirus (HPV) Testing 06.25.2021  
J15 Post Pay Resumptive Review Status Update 01/01/2021 – 03/31/2021 06.22.2021  
Chimeric Antigen Receptor (CAR) T-Cell Therapy 05.25.2021  
Notification of Service Specific Post Payment Review for Psychotherapy: Codes 90832, 90834, 90837 04.26.2021  
Vitamin D Deficiency Screening in Adults 04.26.2021  
Split/Shared Services 03.22.2021 07.16.24
Notification of Service Specific Post Payment Review for Physical Therapy/Occupational Therapy: CPT Codes 97110, 97112, 97140, 97530 03.22.2021  
CGS Coverage for PROPEL Mometasone Furoate Sinus implant 03.18.2021  
J15 Post Pay Resumptive Review Status Update 08/17/2020 – 12/31/2020 03.02.2021  
Parenteral Iron Therapy Article 12.08.2020  
Use of Human Amniotic Based Products 12.02.2020  
Non-covered Services/Category III CPT Code Utilization ADR Checklist 10.28.2020  
Coding Encounter for Aftercare and Medical Care 08.31.2020  
MACs Resume Medical Review on a Post-Payment Basis 08.11.2020  
Reducing Denials through Correct Coding 06.18.2020  
CGS is Retiring Policy L34370 Category III CPT Codes 05.27.2020  
CGS is Retiring Policy L34093 Chemotherapy and Biologicals 04.16.2020  
Micro-Invasive Glaucoma Surgery (MIGS) L37578 Update 12.19.2019  
Policy Billing and Coding Articles Updated During Annual HCPCS and ICD-10 Updates 12.19.2019  
Documentation Reminder for TAVR 12.13.2019  
J15 Targeted Probe and Educate Status Update July 1, 2019 – September 30, 2019 11.22.2019  
J15 Targeted Probe and Educate Status Update: April 1, 2019 – June 30, 2019 08.29.2019  
Prolonged Services (CPT Codes 99354 – 99359) 08.21.2019  
Dual Diagnosis Requirements – Claims Submission 08.15.2019  
Part B Medicare Coverage for Cochlear Implant Batteries 08.02.2019  
Cecostomy Irrigation System Billing Guidelines 05.07.2019 05.31.2019
CGS Part B Reviews of Outpatient Psychotherapy Services 03.26.2019  
Q4 J15 Targeted Probe and Educate Status Update 02.01.2019  
CGS Part B Reviews of Frequency of E/M Office Visits 10.30.2018  
Policy Updates: New, Retired, Annual ICD-10 Changes 10.23.2018  
Targeted Probe and Education Program to Focus on Physical Therapy (PT) and Occupational Therapy (OT) Claims 10.09.2018  
Portable X-Ray Benefit 09.19.2018  
Who May Report CPT Codes 99304 – 99306 Initial Nursing Facility Care 09.18.2018  
Billing and Coding for the Rezum® System for Benign Prostatic Hyperplasia (BPH) 08.02.2018  
Independent Diagnostic Testing Facility (IDTF) Performance Standards (V10) 05.02.2018 10.16.2020
IUD (Hormone-Eluting) for Endometrial Hyperplasia – CPT code 58999 04.10.2018  
Additional Information Regarding NCD 80.11 – Vitrectomy 03.07.2018 08.06.2018
Additional Information Regarding NCD110.21 – Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions 03.07.2018 08.06.2018
How to Avoid Lab Errors 02.27.2018 08.06.2018
Modifier 25 01.11.2018 08.24.2018
What Are Acceptable Electronic Signature Notations? 09.26.2017 01.14.2022
Non-Physicians Acting as Scribes for Physicians 06.06.2017 08.24.2018
SLEEP LAB CREDENTIALING: Polysomnography and Other Sleep Studies (L36902) 05.10.2017 08.06.2018
Removal of Implantable Devices 04.12.2017 04.11.2019
Frequency of General Modalities for Outpatient Physical and Occupational Therapy 04.10.2017 08.24.2018
Clarification of CPT Code 99153 03.16.2017 04.08.2019
Coding to describe STELARA® (ustekinumab) for Intravenous Administration 01.17.2017 08.24.2018
Results of Widespread Prepayment Probe Conducted for OH and KY: Drugs Administered for Macular Degeneration 10.25.2016  
New vs Established Patients 07.19.2016 08.24.2018
Important: JW Modifier Use Change Effective July 1, 2016 06.01.2016 06.20.2016
CGS-MolDX: Next Generation Sequencing (NGS) and Tier 1 and Tier 2 Coding and Billing Guidelines (CM00096) 02.09.2016  
"I'm just an employee. I have nothing to do with coding or billing." 02.03.2016  
Entries in Medical Records: Amendments, Corrections, and Delayed Entries 01.19.2016  
2016 MoPath Tier 2 Fee Schedule (CM00094) 01.11.2016  
Coding Questions: Where to Go for Help 04.24.2015 08.06.2018
Chronic Care Management (CPT Code 99490) 03.24.2015 08.24.2018
Solesta™ Treatment for Fecal Incontinence 02.06.2015 07.23.2021
Signatures and Compliance: Practitioner Offices and Billing Services 03.06.2014 12.13.2023
Teaching Physician Services: Supervision, Documentation, and HCPCS Modifier GC 09.19.2013 05.07.2019
Breast Tomosynthesis: Coverage and Claim Submission Instructions 09.06.2013 01.13.2015
Radiopharmaceutical Drugs – Reminder 03.07.2013  
Reduced Services (CPT Modifier 52) and Discontinued Procedures (CPT Modifier 53): Coding, Documenting, and Payment 03.20.2013 08.24.2018
Entries in Medical Records: Amendments, Corrections, and Addenda 12.28.2012 01.19.2016
Electronic Medical Record Tips 09.06.2012 08.06.2018

Updated: 02.27.2025

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © 2025 CGS Administrators, LLC. All Rights Reserved